Discontinued — last reported Q2 '22
Becton, Dickinson and Company EMEA — Revenue decreased by 10.2% to $4.71B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.2%, from $4.48B to $4.71B. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates successful market expansion or higher demand for medical products in the region, while a decrease may signal competitive pressure or regional economic headwinds.
This metric represents the total net sales generated by the company's operations within the Europe, Middle East, and Afr...
Comparable to regional revenue reporting by other global medical technology firms, which typically benchmark growth against regional GDP and healthcare spending trends.
bdx_segment_emea_revenues| Q2 '21 | Q2 '21 | Q3 '21 | Q3 '21 | Q4 '21 | Q4 '21 | Q1 '22 | Q1 '22 | Q2 '22 | Q2 '22 | Q3 '22 | Q3 '22 | Q4 '22 | Q4 '22 | Q1 '23 | Q1 '23 | Q2 '23 | Q2 '23 | Q3 '23 | Q3 '23 | Q4 '23 | Q4 '23 | Q1 '24 | Q1 '24 | Q2 '24 | Q2 '24 | Q3 '24 | Q3 '24 | Q4 '24 | Q4 '24 | Q1 '25 | Q1 '25 | Q2 '25 | Q2 '25 | Q3 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.61B | $1.19B | $4.30B | $1.19B | $4.72B | $1.01B | $4.75B | $1.01B | $4.64B | $1.01B | $4.76B | $1.01B | $4.59B | $1.06B | $4.82B | $1.06B | $4.88B | $1.06B | $5.09B | $1.06B | $4.71B | $1.10B | $5.05B | $1.10B | $4.99B | $1.10B | $5.44B | $1.10B | $5.17B | $1.18B | $4.48B | $1.18B | $5.51B | $1.18B | $6.68B | $1.18B | $5.25B | $4.71B |
| QoQ Change | — | -74.2% | +262.2% | -72.4% | +297.2% | -78.6% | +369.9% | -78.7% | +359.2% | -78.2% | +371.0% | -78.8% | +353.7% | -76.9% | +354.4% | -78.0% | +359.8% | -78.2% | +379.5% | -79.1% | +343.5% | -76.6% | +358.4% | -78.2% | +353.4% | -77.9% | +394.0% | -79.8% | +369.6% | -77.1% | +278.9% | -73.6% | +366.0% | -78.5% | +465.3% | -82.3% | +344.2% | -10.2% |
| YoY Change | — | — | — | — | — | — | — | — | +0.7% | -78.1% | +10.7% | -76.5% | -2.8% | -77.5% | +1.5% | -77.7% | +5.1% | -77.1% | +6.8% | -77.7% | +2.6% | -76.0% | +4.6% | -77.2% | +2.3% | -77.4% | +6.9% | -78.4% | +9.8% | -74.9% | -11.2% | -76.6% | +10.4% | -76.3% | +22.9% | -78.3% | +1.6% | +5.2% |